Extremely Dose Escalated Radiation Therapy Improves Cancer-Specific Survival Compared With Radical Prostatectomy or Conventionally Dose-Escalated Radiation Therapy in Gleason Score 9-10 Prostate Adenocarcinoma: A Multi-institutional Analysis of 1403 Patie

被引：1

作者：

Kishan, A. U. ^{[1
]}

Ciezki, J. P. ^{[2
]}

Ross, A. E. ^{[3
]}

Cook, R. R. ^{[4
]}

Shaikh, T. ^{[5
]}

Stock, R. G. ^{[6
]}

Merrick, G. S. ^{[7
]}

Demanes, D. J. ^{[4
]}

Alam, R. ^{[3
]}

Spratt, D. E. ^{[8
]}

Abu-Isa, E. I. ^{[8
]}

Wedde, T. ^{[9
]}

Lilleby, W. ^{[9
]}

Sandler, K. A. ^{[10
]}

Song, D. ^{[11
]}

Reddy, C. A. ^{[2
]}

Nickols, N. ^{[12
]}

Steinberg, M. L. ^{[4
]}

Horwitz, E. M. ^{[5
]}

King, C. R.

机构：

[1] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA

[2] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA

[3] Johns Hopkins Med, Baltimore, MD USA

[4] Univ Calif Los Angeles, Los Angeles, CA USA

[5] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[6] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[7] Schiffler Canc Ctr, Wheeling, WV USA

[8] Univ Michigan, Ann Arbor, MI 48109 USA

[9] Norwegian Radium Hosp, Oslo, Norway

[10] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[11] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA

[12] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期

关键词：

D O I：

10.1016/j.ijrobp.2017.06.306

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

282

引用

页码：S131 / S131

页数：1

共 50 条

[31] Heterogeneous Dose-Escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Phase 2 Study
Parsai, S.
Juloori, A.
Reddy, C. A.
Thousand, R.
Magnelli, A.
Balik, S.
Berglund, R.
Stovsky, M.
Klein, E. A.
Tendulkar, R. D.
Stephans, K. L.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E133 - E133
[32] Dose-escalated Adaptive Image Guided Radiation Therapy Versus High-dose-rate Brachytherapy Monotherapy for Gleason 7 Intermediate-Risk Prostate Cancer: A Matched Pair Analysis
Marina, O.
Gustafson, G. S.
Brabbins, D. S.
Wallace, M.
Ye, H.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S369 - S370
[33] PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era
McGuire, Sean E.
Lee, Andrew K.
Cerne, Jasmina Z.
Munsell, Mark F.
Levy, Lawrence B.
Kudchadker, Rajat J.
Choi, Seungtaek L.
Nguyen, Quynh N.
Hoffman, Karen E.
Pugh, Thomas J.
Frank, Steven J.
Corn, Paul G.
Logothetis, Christopher J.
Kuban, Deborah A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01): : E39 - E46
[34] The interval to biochemical failure versus biochemical failure as predictors for cause specific and overall survival following dose-escalated external beam radiation therapy for prostate cancer.
Kapadia, N. S.
Feng, F. Y.
Olson, K. B.
Sandler, H. M.
Hamstra, D. A.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[35] Retrospective Evaluation Reveals That Long-term Androgen Deprivation Therapy Improves Cause-Specific and Overall Survival in the Setting of Dose-Escalated Radiation for High-Risk Prostate Cancer
Feng, Felix Y.
Blas, Kevin
Olson, Karin
Stenmark, Matthew
Sandler, Howard
Hamstra, Daniel A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (01): : 64 - 71
[36] Re: Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi- institutional Comparative Analysis
Tilki, Derya
Evans, Christopher P.
EUROPEAN UROLOGY, 2016, 70 (06) : 1079 - 1080
[37] Whole Pelvis Radiation Therapy Does Not Significantly Improve Prostate-Cancer Specific Survival in Patients With Gleason Score 9-10 Prostate Adenocarcinoma: An Analysis of 942 Patients Treated in the Modern Era
Sandler, K. A.
Cook, R. R.
Ciezki, J. P.
Shaikh, T.
Stock, R. G.
Merrick, G. S.
Demanes, D. J.
Spratt, D. E.
Abu-Isa, E. I.
Wedde, T.
Lilleby, W.
Krauss, D. J.
Song, D.
Alam, R.
Reddy, C. A.
Nickols, N.
Steinberg, M. L.
Horwitz, E. M.
King, C. R.
Kishan, A. U.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E263 - E263
[38] Long-term Androgen Deprivation Therapy Improves Metastasis Free and Cause-specific Survival Even in the Setting of Dose Escalated Radiation for Localized Prostate Cancer
Blas, K.
Feng, F. Y.
Halverson, S.
Lee, V.
Sabolch, A.
Olson, K.
Sandler, H. M.
Hamstra, D. A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S125 - S125
[39] Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes
Kotecha, Rupesh
Djemil, Toufik
Tendulkar, Rahul D.
Reddy, Chandana A.
Thousand, Richard A.
Vassil, Andrew
Stovsky, Mark
Berglund, Ryan K.
Klein, Eric A.
Stephans, Kevin L.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (03): : 960 - 964
[40] The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer
Shilkrut, Mark
Merrick, Gregory S.
McLaughlin, P. William
Stenmark, Matthew H.
Abu-Isa, Eyad
Vance, Sean M.
Sandler, Howard M.
Feng, Felix Y.
Hamstra, Daniel A.
CANCER, 2013, 119 (03) : 681 - 690

← 1 2 3 4 5 →